Nasal absorption of mixtures of fast-acting and long-acting insulins

International Journal of Pharmaceutics

Volumn 388, Issue 1-2, 2010, Pages 202-208

  Pillion, Dennis J ^a   Fyrberg, Michael D ^a   Meezan, Elias ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Absorption enhancer; Diabetes; Drug delivery; Insulin; Nasal absorption; Surfactants

Indexed keywords

DISACCHARIDE; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; RECOMBINANT HUMAN INSULIN; TETRADECYL BETA DEXTRO MALTOSIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ABSORPTION; DRUG FORMULATION; DRUG MIXTURE; DRUG SOLUBILITY; HYPERGLYCEMIA; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, INTRANASAL; ANIMALS; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; EXCIPIENTS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MALTOSE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 76549119332     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.01.013     Document Type: Article

References (17)

1. Ahsan F., Arnold J.J., Yang T., Meezan E., Schwiebert E.M., and Pillion D.J. Effects of the permeability enhancers, tetradecylmaltoside and dimethyl-β-cyclodextrin, on insulin movement across human bronchial epithelial cells 16HBE 14o. Eur. J. Pharm. Sci. 20 (2003) 27-34
2. Arnold, J.J., 2004. Systemic delivery of peptides and macromolecules in nasal formulations containing an alkylglycoside. Doctoral Dissertation. University of Alabama at Birmingham.
3. Arnold J.J., Ahsan F., Meezan E., and Pillion D.J. Nasal administration of low molecular weight heparin. J. Pharm. Sci. 91 (2002) 1707-1714
4. Arnold J.J., Ahsan F., Meezan E., and Pillion D.J. Correlation of tetradecylmaltoside induced increase in nasal peptide drug delivery with morphological changes in nasal epithelial cells. J. Pharm. Sci. 93 (2004) 2205-2213
5. Arnold, J.J., Fyrberg, M.D., Meezan, E., Pillion, D.J., in press. Reestablishment of the nasal permeability barrier to several peptides following exposure to the absorption enhancer tetradecyl-β-d-maltoside. J Pharm Sci. 2009 Nov 5. [Epub ahead of print] PMID: 19894270.
6. Benedict C., Hallschmid M., Schmitz K., Schultes B., Ratter F., Fehm H.L., Born J., and Kern W. Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology 32 (2007) 239-243
7. Illum L. Nasal drug delivery-possibilities, problems and solutions. J. Control. Release 87 (2003) 187-198
8. Kaplan W., Rodriguez L., Smith O.E., Haymond M.W., and Heptulla R.A. Effects of mixing glargine and short-acting insulin analogs on glucose control. Diabetes Care 27 (2004) 2739-2740
9. Maggio E.T. Intravail™: highly effective intranasal delivery of peptide and protein drugs. Expert Opin. Drug Deliv. 3 (2006) 529-539
10. Newman S.P., Steed K.P., Hardy J.G., Wilding I.R., Hooper G., and Sparrow R.A. The distribution of an intranasal insulin formulation in healthy volunteers: effect of different administration techniques. J. Pharm. Pharmacol. 46 (1994) 657-660
11. Pillion D.J., Ahsan F., Arnold J.J., Balusubramanian B.M., Piraner O., and Meezan E. Synthetic long-chain alkyl maltosides and alkyl sucrose esters as enhancers of nasal insulin absorption. J. Pharm. Sci. 91 (2002) 1456-1462
12. Pillion D.J., Arnold J.J., and Meezan E. In: Touitou E., and Boyd B.W. (Eds). Nasal Delivery of Peptide Drugs in Enhancement in Drug Delivery (2007) 373-392 (Chapter 20)
13. Pillion D.J., Atchison J., Garguilo C., Wang R.X., Wang P., and Meezan E. Insulin delivery in nosedrops: new formulations containing alkylglycosides. Endocrinology 135 (1994) 2386-2391
14. Pillion D.J., Hosmer S., and Meezan E. Dodecylmaltoside-mediated nasal and ocular absorption of lyspro-insulin: independence of surfactant action from multimer dissociation. Pharm. Res. 15 (1998) 1637-1639
15. Reger M.A., Watson G.S., Green P.S., Wilkinson C.W., Baker L.D., Cholerton B., Fishel M.A., Rlymate S.R., Beitner J.C.S., DeGroodt W., Mehta P., and Craft S. Intranasal insulin improves cognition and modulates β-amyloid in early AD. Neurology 70 (2008) 440-448
16. Saha J.K., Xia J., Engle S.K., Chen Y., Glaesner W., and Jaubowski J.S. A model of controlled acute hyperglycemia in rats: effects of insulin and glucagon-like peptide-1 analog. J. Pharm. Exp. Res. 316 (2006) 1159-1164
17. Saha J.K., Xia J., Grondin J., Engle S.K., and Jaubowski J.S. Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical models. Exp. Biol. Med. 230 (2005) 777-784